Paxil CR Bioequivalence Study Brazil - Fed Administration
Status:
Completed
Trial end date:
2009-11-16
Target enrollment:
Participant gender:
Summary
The study is prospective, open, randomized, crossover in steady state and the volunteers
received multiple doses of the test drug and the reference drug (two periods of drug
administration after standardized meals).